Evidence-based recommendations on mobocertinib (EXKIVITY) for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapy in adults.
Commercial arrangement
There is a simple discount patient access scheme for mobocertinib. NHS organisations ca...
Evidence-based recommendations on upadacitinib (Rinvoq) for treating moderately to severely active ulcerative colitis in adults.
Commercial arrangement
There is a simple discount patient access scheme for upadacitinib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. ...
This guideline covers the management of COVID-19 for children, young people and adults in all care settings. It brings together our existing recommendations on managing COVID-19, and new recommendations on therapeutics, so that healthcare staff and those planning and delivering services can find and use ...
COVID-19/tratamiento farmacológico,
Corticoesteroides/uso terapéutico,
Antivirales/uso terapéutico,
COVID-19/complicaciones,
Embolia Pulmonar/complicaciones,
Pulmón/patología,
Anticoagulantes/uso terapéutico,
Dabigatrán/uso terapéutico,
Heparina/uso terapéutico,
4-Hidroxicumarinas/uso terapéutico,
Aspirina/uso terapéutico
This guideline covers vitamin D use in the context of COVID‑19. It is for adults, young people and children in hospitals and community settings. Vitamin D is important for bone and muscle health. It may also have a role in the body's immune response to respiratory viruses. On 14 July 2022, we removed t...
This guideline was developed before the COVID-19 pandemic. It covers diagnosing and managing pneumonia in adults who do not have COVID-19. It aims to improve accurate assessment and diagnosis of pneumonia to help guide antibiotic prescribing and ensure that people receive the right treatment.
July 2022:...
This guideline covers ways to support social, emotional and mental wellbeing in children and young people in primary and secondary education (key stages 1 to 5), and people 25 years and under with special educational needs or disability in further education colleges. It aims to promote good social, emoti...
This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for people with multiple sclerosis by promoting prompt and effective symptom management and relapse treatment, and comprehensive reviews.
NICE has also produced technology ...
Esclerosis Múltiple/terapia,
Esclerosis Múltiple/diagnóstico,
Ataxia/terapia,
Inhibidores Selectivos de la Recaptación de Serotonina/uso terapéutico,
Fatiga/terapia,
Esclerosis Múltiple/rehabilitación,
Fatiga/tratamiento farmacológico,
Limitación de la Movilidad,
Espasticidad Muscular/tratamiento farmacológico,
Distonía/tratamiento farmacológico,
Temblor/tratamiento farmacológico
This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes. It includes advice on diagnosis, education and support, blood glucose management, cardiovascular risk, and identifying and managing long-term complications.
In June 2022, we reviewed the evidence and made new re...
This guideline covers identifying, treating and managing depression in people aged 18 and over. It recommends treatments for first episodes of depression and further-line treatments, and provides advice on preventing relapse, and managing chronic depression, psychotic depression and depression with a coe...
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.
In June 2022, we reviewed the evidence and mad...
